
Ambalal Sarabhai Enterprises Ltd is Rated Sell
2026-04-29 10:10:53Ambalal Sarabhai Enterprises Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 13 March 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 29 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.
Read full news article
Ambalal Sarabhai Enterprises Ltd: Valuation Shifts Signal Changing Price Attractiveness
2026-04-28 08:01:40Ambalal Sarabhai Enterprises Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable shift in its valuation parameters, moving from an attractive to a fair valuation grade. This change reflects evolving market perceptions amid mixed financial metrics and a challenging sector backdrop, prompting investors to reassess the stock’s price attractiveness relative to its peers and historical benchmarks.
Read full news article
Ambalal Sarabhai Enterprises Ltd: Valuation Shifts Signal Renewed Price Attractiveness
2026-04-22 08:01:28Ambalal Sarabhai Enterprises Ltd has witnessed a notable shift in its valuation parameters, moving from an attractive to a very attractive rating, despite a recent downgrade in its overall Mojo Grade to Sell. This change reflects a significant improvement in price-to-earnings and price-to-book value metrics, positioning the micro-cap pharmaceutical player favourably against its peers amid a backdrop of mixed stock performance and sector challenges.
Read full news article
Ambalal Sarabhai Enterprises Ltd is Rated Sell
2026-04-18 10:10:38Ambalal Sarabhai Enterprises Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 13 March 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 18 April 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article
Ambalal Sarabhai Enterprises Ltd is Rated Sell
2026-04-07 10:10:31Ambalal Sarabhai Enterprises Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 13 March 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 07 April 2026, providing investors with the latest insights into its performance and outlook.
Read full news article
Ambalal Sarabhai Enterprises Ltd is Rated Sell
2026-03-27 10:10:41Ambalal Sarabhai Enterprises Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 13 March 2026. While the rating was revised on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 27 March 2026, providing investors with the latest insights into the company’s performance and outlook.
Read full news article
Ambalal Sarabhai Enterprises Ltd Upgraded to Sell on Technical Improvements Despite Weak Fundamentals
2026-03-16 08:12:30Ambalal Sarabhai Enterprises Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 13 March 2026, reflecting a nuanced shift in its technical outlook despite persistent fundamental challenges. The company’s Mojo Score now stands at 34.0, signalling cautious optimism amid a micro-cap pharmaceutical sector environment marked by volatility and selective recovery.
Read full news article
Ambalal Sarabhai Enterprises Ltd is Rated Sell
2026-03-15 10:10:32Ambalal Sarabhai Enterprises Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 13 March 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 15 March 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article
Ambalal Sarabhai Enterprises Ltd is Rated Strong Sell
2026-03-03 10:10:34Ambalal Sarabhai Enterprises Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 03 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.
Read full news articleCorporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available






